Our results showing that binding of cellular integrin α5β1 to its exosomal ligand Dis-ADAM17 mediated the initial interaction of exosomes with recipient cancer cells and that this process was negatively regulated by CD9 prompted us to investigate if these molecules also had an effect in the subsequent exosome uptake by these cells. Here, ADAM17 is linked to cancer.